中文 | English
Return
Total: 66 , 1/7
Show Home Prev Next End page: GO
Author:(Jiangping XU)

1.Phosphodiesterase 4 as a target for the development of novel drugs against cognitive impairment:research advances

Haitao WANG ; Jiangping XU

Journal of International Pharmaceutical Research 2016;(1):44-49

2.Cell adhesion molecules and new drug research

Yufang CHENG ; Jiangping XU ;

Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(01):-

3.Oxidative stress and Alzheimer's disease

Yeye ZHUO ; Hanting ZHANG ; Jiangping XU

Chinese Pharmacological Bulletin 2010;26(4):435-437

4.Contrast-enhanced CT vs. X-ray examination in pest-operative breast cancer

Nini XU ; Jiangping ZHOU ; Hai ZHOU

Chinese Journal of General Practitioners 2009;08(6):403-404

5.Ischemic Brain Injury-Induced Neurogenesis and Its Regulation

Lingxia LI ; Yufang CHENG ; Jiangping XU

International Journal of Cerebrovascular Diseases 2008;16(11):866-869

6.Sedative and hypnotic effect of sulfated polysaccharide from brown seaweed

Lisha SUN ; Lin LI ; Jiangping XU

Chinese Journal of Tissue Engineering Research 2006;10(3):127-129

7.Effects of ginkgolide on cerebral blood flow in dogs

Jiangping XU ; Lin LI ; Lisha SUN

Journal of Integrative Medicine 2005;3(1):50-3

8.Effect of bevacizumab on apoptosis of drug-resistant nasopharyngeal carcinoma cells

Tingting SUN ; Jiangping XU ; Hui LIU

Medical Journal of Chinese People's Liberation Army 2001;0(12):-

9.Advances in research on pharmacological strategies for spinal cord injury

Fengjun DENG ; Yingbao YANG ; Jiangping XU

Chinese Pharmacological Bulletin 1987;0(02):-

10.Monoclonal origin of multifocal urothelial carcinoma

Jiangping GAO ; Yuezeng WANG ; Yong XU

Chinese Journal of Urology 2000;0(01):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 66 , 1/7 Show Home Prev Next End page: GO